对肝细胞癌的基于TLR的治疗策略
Manoj Kumar Gupta1, Ramakrishna Vadde2
1Department of Biotechnology and Bioinformatics, Yogi Vemana University, Kadapa, Andhra Pradesh 516005, India; Hematology, Hemostasis, Oncology, and Stem Cell Transplantation, Hannover Medical School, Hannover 30625, Germany.
Cytokine & growth factor reviews
|August 12, 2025
概括
收费类受体 (TLRs) 在肝细胞癌 (HCC) 的发展和进展中起着复杂的作用. 了解它们的双重功能是开发针对这种常见肝癌的向治疗的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题,经常与慢性炎症和免疫失调有关.
- 托尔类受体 (TLRs) 对于先天性免疫至关重要,与肝病的进展和癌症的发展有关.
- TLRs在瘤微环境中的HCC细胞和免疫细胞中表达,从而影响病变发生.
研究的目的:
- 审查和评估托尔类受体 (TLR) 在肝细胞癌 (HCC) 中信号传递的多方面的作用.
- 探索TLRs对HCC发展,疾病进展和潜在治疗策略的影响.
- 分析TLR多态化对HCC风险和复发的影响.
主要方法:
- 文献综述综合了当前关于TLR信号在HCC中的研究.
- 对研究TLR表达和功能在HCC细胞和瘤微环境中的研究进行分析.
- 检查TLR多态度的研究及其与HCC结果的关联.
主要成果:
- TLRs在HCC中表现出双重作用,可能根据细胞环境和微环境促进或抑制瘤进展.
- 特定的TLR多态 (例如TLR1 rs5743551,TLR4 rs1927914) 与炎症,感染风险和HCC复发有关.
- 临床前数据表明TLR激动剂可以增强免疫疗法,但临床转化受到患者可变反应的限制.
结论:
- TLR信号通路显著影响肝细胞癌 (HCC) 病原发生,为治疗带来挑战和机遇.
- TLR激动剂的可变效应强调了需要个性化的方法,包括患者特定的TLR分析和生物标志物开发.
- 未来的战略应侧重于将TLR向治疗与其他治疗相结合,以提高HCC管理中的疗效和患者结果.
相关概念视频
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K